Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1335990

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1335990

North America API Intermediate Market Size, Share & Industry Trends Analysis Report By Type, By End User, By Application, By Country and Growth Forecast, 2023 - 2030

PUBLISHED:
PAGES: 107 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Multi User License)
USD 1800
PDF (Corporate User License)
USD 2520

Add to Cart

The North America API Intermediate Market would witness market growth of 6.5% CAGR during the forecast period (2023-2030).

Active pharmaceutical ingredients (APIs), the essential elements of pharmaceutical medications, are synthesized from chemical molecules known as intermediates, also referred to as active pharmaceutical ingredient intermediates. These intermediates have a variety of uses and are essential to the pharmaceutical manufacturing process. The development stage of novel pharmaceutical substances makes use of API intermediates. API intermediates' precursor molecules or building blocks are used to create APIs. In quality control processes, API intermediates are used as reference standards.

The increase in the number of elderly populations, the rise in chronic illness populations, and the prominence of market participants are the main factors driving the expansion of the market size. For instance, API intermediates manufacture medications for diabetes, gastrointestinal, lung disease, anti-cancer, anti-histamine, anti-psychotic, and anti-diabetic conditions. Thus, it is projected that increasing rates of chronic illnesses like cancer, cardiac diseases, respiratory disorders, and orthopaedic diseases will propel market expansion.

Lung cancer has been diagnosed in the majority of patients in the last five years. In the United States, tens of thousands of people are treated for non- small cell lung cancer (NSCLC) each year. As a result of the rising prevalence of lung cancer, the market is predicted to rise. Based on Canadian Cancer Statistics, 43% of Canadian women and 45% of Canadian men will develop cancer during their lifetime. The number of new cancer cases continues to rise steadily as the Canadian population grows and ages. Also, the prevalence of other chronic conditions is rising in the regional nations. With this rising number of cancer cases, the need for items such as API intermediate would grow, thereby leading to regional market growth.

The US market dominated the North America API Intermediate Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $50.6 billion by 2030. The Canada market is poised to grow at a CAGR of 8.9% during (2023 - 2030). Additionally, The Mexico market would witness a CAGR of 8% during (2023 - 2030).

Based on Type, the market is segmented into Bulk Drug Intermediates, and Chemical Intermediates. Based on End User, the market is segmented into Biotech & Pharmaceutical Companies, CMO, and Others. Based on Application, the market is segmented into Analgesics, Antidiabetic Drugs, Anti-Infective Drugs, Cardiovascular Drugs, Anticancer Drugs, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Cation Pharma, Espee Group, Sandoo Pharmaceuticals and Chemicals Co., Ltd., Cipla Limited, Cambrex Corporation, Vertellus, Dr. Reddy's Laboratories Ltd., Evonik Industries AG (RAG-Stiftung), Pfizer, Inc., Shree Ganesh Remedies Limited

Scope of the Study

Market Segments covered in the Report:

By Type

  • Bulk Drug Intermediates
  • Chemical Intermediates

By End User

  • Biotech & Pharmaceutical Companies
  • CMO
  • Others

By Application

  • Analgesics
  • Antidiabetic Drugs
  • Anti-Infective Drugs
  • Cardiovascular Drugs
  • Anticancer Drugs
  • Others

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Companies Profiled

  • Cation Pharma
  • Espee Group
  • Sandoo Pharmaceuticals and Chemicals Co., Ltd.
  • Cipla Limited
  • Cambrex Corporation
  • Vertellus
  • Dr. Reddy's Laboratories Ltd.
  • Evonik Industries AG (RAG-Stiftung)
  • Pfizer, Inc.
  • Shree Ganesh Remedies Limited

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 North America API Intermediate Market, by Type
    • 1.4.2 North America API Intermediate Market, by End User
    • 1.4.3 North America API Intermediate Market, by Application
    • 1.4.4 North America API Intermediate Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
  • 3.3 Porter's Five Forces Analysis

Chapter 4. Strategies Deployed in API Intermediate Market

Chapter 5. North America API Intermediate Market by Type

  • 5.1 North America Bulk Drug Intermediates Market by Country
  • 5.2 North America Chemical Intermediates Market by Country

Chapter 6. North America API Intermediate Market by End User

  • 6.1 North America Biotech & Pharmaceutical Companies Market by Country
  • 6.2 North America CMO Market by Country
  • 6.3 North America Others Market by Country

Chapter 7. North America API Intermediate Market by Application

  • 7.1 North America Analgesics Market by Country
  • 7.2 North America Antidiabetic Drugs Market by Country
  • 7.3 North America Anti-Infective Drugs Market by Country
  • 7.4 North America Cardiovascular Drugs Market by Country
  • 7.5 North America Anticancer Drugs Market by Country
  • 7.6 North America Others Market by Country

Chapter 8. North America API Intermediate Market by Country

  • 8.1 US API Intermediate Market
    • 8.1.1 US API Intermediate Market by Type
    • 8.1.2 US API Intermediate Market by End User
    • 8.1.3 US API Intermediate Market by Application
  • 8.2 Canada API Intermediate Market
    • 8.2.1 Canada API Intermediate Market by Type
    • 8.2.2 Canada API Intermediate Market by End User
    • 8.2.3 Canada API Intermediate Market by Application
  • 8.3 Mexico API Intermediate Market
    • 8.3.1 Mexico API Intermediate Market by Type
    • 8.3.2 Mexico API Intermediate Market by End User
    • 8.3.3 Mexico API Intermediate Market by Application
  • 8.4 Rest of North America API Intermediate Market
    • 8.4.1 Rest of North America API Intermediate Market by Type
    • 8.4.2 Rest of North America API Intermediate Market by End User
    • 8.4.3 Rest of North America API Intermediate Market by Application

Chapter 9. Company Profiles

  • 9.1 Cation Pharma
    • 9.1.1 Company Overview
    • 9.1.2 SWOT Analysis
  • 9.2 Espee Group
    • 9.2.1 Company Overview
    • 9.2.2 Recent strategies and developments:
      • 9.2.2.1 Trials and Approvals:
  • 9.3 Sandoo Pharmaceuticals and Chemicals Co., Ltd.
    • 9.3.1 Company Overview
    • 9.3.2 SWOT Analysis
  • 9.4 Cipla Limited
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
    • 9.4.3 Regional Analysis
    • 9.4.4 Research & Development Expense
    • 9.4.5 SWOT Analysis
  • 9.5 Cambrex Corporation
    • 9.5.1 Company Overview
    • 9.5.2 Recent strategies and developments:
      • 9.5.2.1 Acquisition and Mergers:
    • 9.5.3 SWOT Analysis
  • 9.6 Vertellus
    • 9.6.1 Company Overview
    • 9.6.2 SWOT Analysis
  • 9.7 Dr. Reddy's Laboratories Ltd.
    • 9.7.1 Company Overview
    • 9.7.2 Financial Analysis
    • 9.7.3 Segmental and Regional Analysis
    • 9.7.4 Research & Development Expense
    • 9.7.5 Recent strategies and developments:
      • 9.7.5.1 Partnerships, Collaborations, and Agreements:
    • 9.7.6 SWOT Analysis
  • 9.8 Evonik Industries AG (RAG-Stiftung)
    • 9.8.1 Company Overview
    • 9.8.2 Financial Analysis
    • 9.8.3 Segmental and Regional Analysis
    • 9.8.4 Research & Development Expenses
    • 9.8.5 Recent strategies and developments:
      • 9.8.5.1 Partnerships, Collaborations, and Agreements:
      • 9.8.5.2 Geographical Expansions:
    • 9.8.6 SWOT Analysis
  • 9.9 Pfizer, Inc.
    • 9.9.1 Company Overview
    • 9.9.2 Financial Analysis
    • 9.9.3 Regional & Segmental Analysis
    • 9.9.4 Research & Development Expense
    • 9.9.5 Recent strategies and developments:
      • 9.9.5.1 Geographical Expansions:
    • 9.9.6 SWOT Analysis
  • 9.10. SHREE GANESH REMEDIES LIMITED
    • 9.10.1 Company Overview
    • 9.10.2 Financial Analysis
    • 9.10.3 SWOT Analysis

LIST OF TABLES

  • TABLE 1 North America API Intermediate Market, 2019 - 2022, USD Million
  • TABLE 2 North America API Intermediate Market, 2023 - 2030, USD Million
  • TABLE 3 North America API Intermediate Market by Type, 2019 - 2022, USD Million
  • TABLE 4 North America API Intermediate Market by Type, 2023 - 2030, USD Million
  • TABLE 5 North America Bulk Drug Intermediates Market by Country, 2019 - 2022, USD Million
  • TABLE 6 North America Bulk Drug Intermediates Market by Country, 2023 - 2030, USD Million
  • TABLE 7 North America Chemical Intermediates Market by Country, 2019 - 2022, USD Million
  • TABLE 8 North America Chemical Intermediates Market by Country, 2023 - 2030, USD Million
  • TABLE 9 North America API Intermediate Market by End User, 2019 - 2022, USD Million
  • TABLE 10 North America API Intermediate Market by End User, 2023 - 2030, USD Million
  • TABLE 11 North America Biotech & Pharmaceutical Companies Market by Country, 2019 - 2022, USD Million
  • TABLE 12 North America Biotech & Pharmaceutical Companies Market by Country, 2023 - 2030, USD Million
  • TABLE 13 North America CMO Market by Country, 2019 - 2022, USD Million
  • TABLE 14 North America CMO Market by Country, 2023 - 2030, USD Million
  • TABLE 15 North America Others Market by Country, 2019 - 2022, USD Million
  • TABLE 16 North America Others Market by Country, 2023 - 2030, USD Million
  • TABLE 17 North America API Intermediate Market by Application, 2019 - 2022, USD Million
  • TABLE 18 North America API Intermediate Market by Application, 2023 - 2030, USD Million
  • TABLE 19 North America Analgesics Market by Country, 2019 - 2022, USD Million
  • TABLE 20 North America Analgesics Market by Country, 2023 - 2030, USD Million
  • TABLE 21 North America Antidiabetic Drugs Market by Country, 2019 - 2022, USD Million
  • TABLE 22 North America Antidiabetic Drugs Market by Country, 2023 - 2030, USD Million
  • TABLE 23 North America Anti-Infective Drugs Market by Country, 2019 - 2022, USD Million
  • TABLE 24 North America Anti-Infective Drugs Market by Country, 2023 - 2030, USD Million
  • TABLE 25 North America Cardiovascular Drugs Market by Country, 2019 - 2022, USD Million
  • TABLE 26 North America Cardiovascular Drugs Market by Country, 2023 - 2030, USD Million
  • TABLE 27 North America Anticancer Drugs Market by Country, 2019 - 2022, USD Million
  • TABLE 28 North America Anticancer Drugs Market by Country, 2023 - 2030, USD Million
  • TABLE 29 North America Others Market by Country, 2019 - 2022, USD Million
  • TABLE 30 North America Others Market by Country, 2023 - 2030, USD Million
  • TABLE 31 North America API Intermediate Market by Country, 2019 - 2022, USD Million
  • TABLE 32 North America API Intermediate Market by Country, 2023 - 2030, USD Million
  • TABLE 33 US API Intermediate Market, 2019 - 2022, USD Million
  • TABLE 34 US API Intermediate Market, 2023 - 2030, USD Million
  • TABLE 35 US API Intermediate Market by Type, 2019 - 2022, USD Million
  • TABLE 36 US API Intermediate Market by Type, 2023 - 2030, USD Million
  • TABLE 37 US API Intermediate Market by End User, 2019 - 2022, USD Million
  • TABLE 38 US API Intermediate Market by End User, 2023 - 2030, USD Million
  • TABLE 39 US API Intermediate Market by Application, 2019 - 2022, USD Million
  • TABLE 40 US API Intermediate Market by Application, 2023 - 2030, USD Million
  • TABLE 41 Canada API Intermediate Market, 2019 - 2022, USD Million
  • TABLE 42 Canada API Intermediate Market, 2023 - 2030, USD Million
  • TABLE 43 Canada API Intermediate Market by Type, 2019 - 2022, USD Million
  • TABLE 44 Canada API Intermediate Market by Type, 2023 - 2030, USD Million
  • TABLE 45 Canada API Intermediate Market by End User, 2019 - 2022, USD Million
  • TABLE 46 Canada API Intermediate Market by End User, 2023 - 2030, USD Million
  • TABLE 47 Canada API Intermediate Market by Application, 2019 - 2022, USD Million
  • TABLE 48 Canada API Intermediate Market by Application, 2023 - 2030, USD Million
  • TABLE 49 Mexico API Intermediate Market, 2019 - 2022, USD Million
  • TABLE 50 Mexico API Intermediate Market, 2023 - 2030, USD Million
  • TABLE 51 Mexico API Intermediate Market by Type, 2019 - 2022, USD Million
  • TABLE 52 Mexico API Intermediate Market by Type, 2023 - 2030, USD Million
  • TABLE 53 Mexico API Intermediate Market by End User, 2019 - 2022, USD Million
  • TABLE 54 Mexico API Intermediate Market by End User, 2023 - 2030, USD Million
  • TABLE 55 Mexico API Intermediate Market by Application, 2019 - 2022, USD Million
  • TABLE 56 Mexico API Intermediate Market by Application, 2023 - 2030, USD Million
  • TABLE 57 Rest of North America API Intermediate Market, 2019 - 2022, USD Million
  • TABLE 58 Rest of North America API Intermediate Market, 2023 - 2030, USD Million
  • TABLE 59 Rest of North America API Intermediate Market by Type, 2019 - 2022, USD Million
  • TABLE 60 Rest of North America API Intermediate Market by Type, 2023 - 2030, USD Million
  • TABLE 61 Rest of North America API Intermediate Market by End User, 2019 - 2022, USD Million
  • TABLE 62 Rest of North America API Intermediate Market by End User, 2023 - 2030, USD Million
  • TABLE 63 Rest of North America API Intermediate Market by Application, 2019 - 2022, USD Million
  • TABLE 64 Rest of North America API Intermediate Market by Application, 2023 - 2030, USD Million
  • TABLE 65 Key Information - Cation Pharma
  • TABLE 66 Key Information - Espee Group
  • TABLE 67 Key Information - Sandoo Pharmaceuticals and Chemicals Co., Ltd.
  • TABLE 68 Key Information - Cipla Limited
  • TABLE 69 Key Information - Cambrex Corporation
  • TABLE 70 Key Information - Vertellus
  • TABLE 71 key information - Dr. Reddy's Laboratories Ltd.
  • TABLE 72 Key Information - Evonik Industries AG
  • TABLE 73 Key Information - Pfizer, Inc.
  • TABLE 74 Key Information - SHREE GANESH REMEDIES LIMITED

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 North America API Intermediate Market, 2019 - 2030, USD Million
  • FIG 3 Key Impacting Factors API intermediate market
  • FIG 4 Porter's Five Forces Analysis - API Intermediate Market
  • FIG 5 North America API Intermediate Market share by Type, 2022
  • FIG 6 North America API Intermediate Market share by Type, 2030
  • FIG 7 North America API Intermediate Market by Type, 2019 - 2030, USD Million
  • FIG 8 North America API Intermediate Market share by End User, 2022
  • FIG 9 North America API Intermediate Market share by End User, 2030
  • FIG 10 North America API Intermediate Market by End User, 2019 - 2030, USD Million
  • FIG 11 North America API Intermediate Market share by Application, 2022
  • FIG 12 North America API Intermediate Market share by Application, 2030
  • FIG 13 North America API Intermediate Market by Application, 2019 - 2030, USD Million
  • FIG 14 North America API Intermediate Market share by Country, 2022
  • FIG 15 North America API Intermediate Market share by Country, 2030
  • FIG 16 North America API Intermediate Market by Country, 2019 - 2030, USD Million
  • FIG 17 Swot Analysis: Cation Pharma
  • FIG 18 Swot Analysis: Sandoo Pharmaceuticals and Chemicals Co., Ltd.
  • FIG 19 SWOT Analysis: Cipla Limited
  • FIG 20 Swot Analysis: Cambrex Corporation
  • FIG 21 Swot Analysis: Vertellus
  • FIG 22 Swot Analysis: Dr. Reddy's Laboratories Ltd.
  • FIG 23 Recent strategies and developments: Evonik Industries AG
  • FIG 24 Swot Analysis: Evonik Industries AG
  • FIG 25 Swot Analysis: Pfizer, Inc.
  • FIG 26 Swot Analysis: SHREE GANESH REMEDIES LIMITED
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!